Insurance

Dr Megan Althoff on the Difficulties Deciding Between Biologics for Patients With Severe Asthma

October 21st 2020, 5:30pm

Video

Challenges remain, in light of new guidelines, when making treatment decisions for patients with severe asthma, noted Megan Althoff, MD, PhD, second year fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.

How a Supreme Court Vacancy Can Shape the Fate of the ACA, Reproductive Rights

September 22nd 2020, 2:34pm

Article

The passing of Supreme Court Justice Ruth Bader Ginsburg has thrown an already contentious election season into greater limbo, as her death and potential replacement could result in substantial changes to the future of the Affordable Care Act and women’s reproductive rights.

How Can the COVID-19 Pandemic Enhance Value-Based Health Care Delivery?

August 12th 2020, 5:15pm

Video

Given the constraints prevalent post-COVID-19, Dr Mark Fendrick, director of the University of Michigan Center for Value-Based Insurance Design, stresses that it is now more important than ever for the health care industry to prioritize payment reform, value-based benefit design, and novel policy initiatives.

Can a Community-Based Care Management Program Reduce Costs, Visits Among Medicaid Enrollees?

August 6th 2020, 1:00pm

Podcast

Krisda H. Chaiyachati, MD, MPH, MSHP, discusses the study he co-wrote entitled “Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients.”

Trump Signs 4 Executive Orders in Effort to Carry Out Promise to Lower Drug Prices

July 25th 2020, 1:15am

Article

The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices.

What We're Reading: Vaccine Distribution Agreement Announced; Virus Deaths Surge Again; Medicare Insolvency Predicted

July 22nd 2020, 6:22pm

Article

The US government partners with biotech giants Pfizer and BioNTech to distribute a coronavirus disease 2019 (COVID-19) vaccine; the COVID-19 death record continues to be broken; could Medicare be in financial trouble?

CMS Seeks Incentives for At-Home Dialysis in Wake of COVID-19

July 7th 2020, 4:54pm

Article

End-stage renal disease has long been one of the most expensive and debilitating conditions that affects Medicare beneficiaries. Not only does dialysis cost $90,000 a year—those awaiting a kidney transplant automatically qualify for Medicare—but the need to travel to a dialysis center multiple times a week disrupts employment and home life.

Gauging the Experiences of the Seriously Ill in California: Analyzing Serious Illness Beyond Medicare Fee-for-Service

July 2nd 2020, 6:01pm

Article

Significant populations of seriously ill individuals are insured by all lines of business and have meaningfully different needs and medical histories in California.

Study Highlights Variation in Second-Generation Diabetes Drug Use Among Medicare Enrollees

June 22nd 2020, 7:09pm

Article

Among Medicare enrollees, there was substantial between-practice variation in the use of second-generation diabetes drugs between 2007 and 2015, according to a study published in JAMA Network Open. Data also revealed a concentration of use among a few prescribers and practices, who were responsible for widespread early diffusion.

Strategies for Implementing Best Practices in Independent Physician Associations

June 16th 2020, 8:00pm

Article

The objective of this research was to identify strategies that significantly lower unnecessary inpatient utilization among Medicare beneficiaries with chronic disease.